Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults
Clinical trial NCT02014727 · COMPLETED
Trial details
- NCT number
- NCT02014727
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.